<article title='Amoxicillin'><paragraph><template><target>Infobox drug</target><arg name="Watchedfields"><space/>changed
</arg><arg name="verifiedrevid"><space/>455343638
</arg><arg name="drug_name"><space/>Amoxicillin ([[International Nonproprietary Name|INN]], [[British Approved Name|BAN]], [[United States Adopted Name|USAN]])
</arg><arg name="IUPAC_name"><space/>(2''S'',5''R'',6''R'')-6-{[(2''R'')-2-amino-2-(4-hydroxyphenyl)-acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-24-carboxylic acid
</arg><arg name="image"><space/>Amoxicillin.svg
</arg><arg name="image2"><space/>Amoxicillin-3D-balls.png
<space/></arg><arg name="tradename"><space/>Amoxil, Tycil, and Trimox, among others
</arg><arg name="Drugs.com"><space/>{{drugs.com|monograph|amoxicillin}}
</arg><arg name="MedlinePlus"><space/>a685001
</arg><arg name="pregnancy_AU"><space/>A
</arg><arg name="pregnancy_US"><space/>B
</arg><arg name="legal_UK"><space/>POM
</arg><arg name="legal_US"><space/>Rx-only
</arg><arg name="routes_of_administration"><space/>[[Wiktionary:oral|Oral]], [[intravenous therapy|intravenous]]
<space/></arg><arg name="bioavailability"><space/>95% oral
</arg><arg name="metabolism"><space/>less than 30% biotransformed in [[liver]]
</arg><arg name="elimination_half-life"><space/>61.3 minutes
</arg><arg name="excretion"><space/>[[renal]]
<space/></arg><arg name="CAS_number_Ref"><space/>{{cascite|correct|??}}
</arg><arg name="CAS_number"><space/>26787-78-0
</arg><arg name="ATC_prefix"><space/>J01
</arg><arg name="ATC_suffix"><space/>CA04
</arg><arg name="ATC_supplemental"><space/>{{ATCvet|G51|AA03}}
</arg><arg name="ChEBI_Ref"><space/>{{ebicite|correct|EBI}}
</arg><arg name="ChEBI"><space/>2676
</arg><arg name="PubChem"><space/>33613
</arg><arg name="DrugBank_Ref"><space/>{{drugbankcite|correct|drugbank}}
</arg><arg name="DrugBank"><space/>DB01060
</arg><arg name="ChemSpiderID_Ref"><space/>{{chemspidercite|correct|chemspider}}
</arg><arg name="ChemSpiderID"><space/>31006
</arg><arg name="UNII_Ref"><space/>{{fdacite|correct|FDA}}
</arg><arg name="UNII"><space/>9EM05410Q9
</arg><arg name="KEGG_Ref"><space/>{{keggcite|correct|kegg}}
</arg><arg name="KEGG"><space/>D07452
</arg><arg name="ChEMBL_Ref"><space/>{{ebicite|correct|EBI}}
</arg><arg name="ChEMBL"><space/>1082
<space/></arg><arg name="C">16<space/></arg><arg name="H">19<space/></arg><arg name="N">3<space/></arg><arg name="O">5<space/></arg><arg name="S">1
</arg><arg name="molecular_weight"><space/>365.4 g/mol
</arg><arg name="SMILES"><space/>O</arg><arg name="InChI"><space/>1/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1
</arg><arg name="StdInChI_Ref"><space/>{{stdinchicite|correct|chemspider}}
</arg><arg name="StdInChI"><space/>1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1
</arg><arg name="StdInChIKey_Ref"><space/>{{stdinchicite|correct|chemspider}}
</arg><arg name="StdInChIKey"><space/>LSQZJLSUYDQPKJ-NJBDSQKTSA-N
</arg></template></paragraph><preblock><preline><bold>Amoxicillin</bold>, also spelled<space/><bold>amoxycillin</bold><space/>and<space/><bold>amox</bold>, is an<space/><link><target>antibiotic</target></link><space/>useful for the treatment of a number of<space/><link><target>bacterial infection</target><trail>s</trail></link>.<extension extension_name='ref' name="AHFS2015"></extension><space/>It is the first line treatment for<space/><link><target>acute otitis media</target><part>middle ear infections</part></link>. It may also be used for<space/><link><target>strep throat</target></link>,<space/><link><target>pneumonia</target></link>,<space/><link><target>cellulitis</target><part>skin infections</part></link>, and<space/><link><target>urinary tract infection</target><trail>s</trail></link><space/>among others. It is taken by mouth.<extension extension_name='ref' name="AHFS2015"><template><target>cite web</target><arg name="title">Amoxicillin<space/></arg><arg name="url">http://www.drugs.com/monograph/amoxicillin.html</arg><arg name="work">The American Society of Health-System Pharmacists</arg><arg name="accessdate">1 August 2015</arg></template></extension><space/></preline></preblock><preblock><preline>Common side effects include nausea and rash.<extension extension_name='ref' name="AHFS2015"></extension><space/>It may also increase the risk of<space/><link><target>candidiasis</target><part>yeast infections</part></link><space/>and, when used in combination with<space/><link><target>clavulanic acid</target></link>,<space/><link><target>diarrhea</target></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Gillies</arg><arg name="first1">M</arg><arg name="last2">Ranakusuma</arg><arg name="first2">A</arg><arg name="last3">Hoffmann</arg><arg name="first3">T</arg><arg name="last4">Thorning</arg><arg name="first4">S</arg><arg name="last5">McGuire</arg><arg name="first5">T</arg><arg name="last6">Glasziou</arg><arg name="first6">P</arg><arg name="last7">Del Mar</arg><arg name="first7">C</arg><arg name="title">Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication.</arg><arg name="journal">CMAJ : Canadian Medical Association journal<space/></arg><arg name="date">17 November 2014</arg><arg name="pmid">25404399</arg><arg name="doi">10.1503/cmaj.140848</arg><arg name="volume">187</arg><arg name="pages">E21-31</arg></template></extension><space/>It should not be used in those who are allergic to<space/><link><target>penicillin</target></link>. While usable in those with<space/><link><target>kidney problem</target><trail>s</trail></link>, the dose may need to be decreased. Its use in<space/><link><target>pregnancy</target></link><space/>and<space/><link><target>breastfeeding</target></link><space/>appears to be okay.<extension extension_name='ref' name="AHFS2015"></extension></preline></preblock><preblock><preline>Amoxicillin first became available in<space/><link><target>Timeline of antibiotics</target><part>1972</part></link>.<extension extension_name='ref'><template><target>cite book</target><arg name="last1">Roy</arg><arg name="first1">Jiben</arg><arg name="title">An introduction to pharmaceutical sciences production, chemistry, techniques and technology</arg><arg name="date">2012</arg><arg name="publisher">Woodhead Pub.</arg><arg name="location">Cambridge</arg><arg name="isbn">9781908818041</arg><arg name="page">239</arg><arg name="url">https://books.google.ca/books?id</arg></template></extension><space/>It is on the<space/><link><target>World Health Organization's List of Essential Medicines</target></link>, the most important medications needed in a basic<space/><link><target>health system</target></link>.<extension extension_name='ref'><template><target>cite web</target><arg name="title">WHO Model List of EssentialMedicines</arg><arg name="url">http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua</arg><arg name="work">World Health Organization</arg><arg name="accessdate">22 April 2014</arg><arg name="date">October 2013</arg></template></extension><space/>It is one of the most commonly prescribed antibiotics in children.<extension extension_name='ref'><template><target>cite book</target><arg name="last1">Kelly</arg><arg name="first1">Deirdre</arg><arg name="title">Diseases of the liver and biliary system in children</arg><arg name="date">2008</arg><arg name="publisher">Wiley-Blackwell</arg><arg name="location">Chichester, UK</arg><arg name="isbn">9781444300543</arg><arg name="page">217</arg><arg name="edition">3</arg><arg name="url">https://books.google.ca/books?id</arg></template></extension><space/>Amoxicillin is available as a<space/><link><target>generic medication</target></link>.<extension extension_name='ref' name="AHFS2015"></extension><space/>It has a wholesale costs between 0.02 and 0.05 USD per pill.<extension extension_name='ref'><template><target>cite web</target><arg name="title">Amoxicillin</arg><arg name="url">http://erc.msh.org/dmpguide/resultsdetail.cfm?language</arg><arg name="website">International Drug Price Indicator Guide</arg><arg name="accessdate">1 August 2015</arg></template></extension><space/>In the United States ten days of treatment costs about 16 USD.<extension extension_name='ref' name="AHFS2015"></extension></preline></preblock><heading level='2'>Medical uses</heading><paragraph><link><target>Image:Amoxicillin.JPG</target><part>thumb</part><part>right</part><part>Amoxicillin BP</part></link>Amoxicillin is used in the treatment of a number of infections, including<space/><link><target>acute otitis media</target></link>,<space/><link><target>streptococcal pharyngitis</target></link>,<space/><link><target>pneumonia</target></link>,<space/><link><target>Cellulitis</target><part>skin infections</part></link>,<space/><link><target>urinary tract infection</target><trail>s</trail></link>,<space/><italics><link><target>Salmonella</target></link></italics><space/>infections,<space/><link><target>Lyme disease</target></link>, and<space/><link><target>Chlamydia infection</target><part>chlamydia</part></link><space/>infections.<extension extension_name='ref' name="AHFS2015"></extension><space/></paragraph><heading level='3'>Respiratory infections</heading><paragraph>Amoxicillin and amoxicillin-clavulanate have been recommended by guidelines as the drug of choice for bacterial<space/><link><target>sinusitis</target></link>, but most sinusitis is caused by viruses, for which amoxicillin and amoxicillin-clavulanate are ineffective,<space/><extension extension_name='ref' name="AAAAIfive"><template><target>Cite journal</target><arg name="author1"><space/>American Academy of Allergy, Asthma, and Immunology<space/></arg><arg name="author1-link"><space/>American Academy of Allergy, Asthma, and Immunology<space/></arg><arg name="title"><space/>Five Things Physicians and Patients Should Question<space/></arg><arg name="publisher"><space/>[[American Academy of Allergy, Asthma, and Immunology]]<space/></arg><arg name="work"><space/>Choosing Wisely: an initiative of the [[ABIM Foundation]]<space/></arg><arg name="page"><space/></arg><arg name="url"><space/>http://choosingwisely.org/wp-content/uploads/2012/04/5things_12_factsheet_AAAAI.pdf<space/></arg><arg name="accessdate"><space/>August 14, 2012<space/></arg></template></extension><space/>and the small benefit gained by Amoxicillin may be overridden by the adverse effects.<space/><extension extension_name='ref' name="antibioticssinusitis"><template><target>Cite journal</target><arg name="last1"><space/>Ahovuo-Saloranta<space/></arg><arg name="first1"><space/>A. 
</arg><arg name="last2"><space/>Rautakorpi<space/></arg><arg name="first2"><space/>U. M. 
</arg><arg name="last3"><space/>Borisenko<space/></arg><arg name="first3"><space/>O. V. 
</arg><arg name="last4"><space/>Liira<space/></arg><arg name="first4"><space/>H. 
</arg><arg name="last5"><space/>Williams Jr<space/></arg><arg name="first5"><space/>J. W. 
</arg><arg name="last6"><space/>Mäkelä<space/></arg><arg name="first6"><space/>M. 
</arg><arg name="editor1-last"><space/>Ahovuo-Saloranta 
</arg><arg name="editor1-first"><space/>Anneli 
</arg><arg name="title"><space/>Antibiotics for acute maxillary sinusitis 
</arg><arg name="doi"><space/>10.1002/14651858.CD000243.pub3
</arg><arg name="journal"><space/>The Cochrane Library
</arg><arg name="year"><space/>2014
</arg><arg name="pmid"><space/>
</arg><arg name="pmc"><space/>
</arg></template></extension><space/>Amoxicillin is recommended as the preferred first-line treatment for commmunity-acquired pneumonia in adults by the<space/><link><target>National Institute for Health and Care Excellence</target></link>, either alone (mild to moderate severity disease) or in combination with a macrolide.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0071334/<space/></arg><arg name="title">Pneumonia - National Library of Medicine - PubMed Health<space/></arg><arg name="format"><space/></arg><arg name="work"><space/></arg><arg name="accessdate"></arg></template></extension><space/>The World Health Organization recommends amoxicillin as first-line treatment for pneumonia that is not &quot;severe&quot;.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.ncbi.nlm.nih.gov/books/NBK264162/<space/></arg><arg name="title">Revised WHO Classification and Treatment of Pneumonia in Children at Health Facilities - NCBI Bookshelf<space/></arg><arg name="format"><space/></arg><arg name="work"><space/></arg><arg name="accessdate"></arg></template></extension></paragraph><heading level='3'>Skin infections</heading><paragraph>Amoxicillin is occasionally used for the treatment of skin infections, such as<space/><link><target>acne vulgaris</target></link>.<extension extension_name='ref'><template><target>cite web</target><arg name="title"><space/>Adolescent Acne: Management<space/></arg><arg name="url"><space/>http://www.medscape.com/viewarticle/430534_5</arg></template></extension><space/>It is often an effective treatment for cases of acne vulgaris that have responded poorly to other antibiotics, such as<space/><link><target>doxycycline</target></link><space/>and<space/><link><target>minocycline</target></link>.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://scienceofacne.com/amoxicillin/</arg><arg name="title">Amoxicillin and Acne Vulgaris<space/></arg><arg name="publisher">scienceofacne.com<space/></arg><arg name="date">2012-09-05<space/></arg><arg name="accessdate">2012-08-17</arg></template></extension></paragraph><heading level='3'>Infections in infants in resource-limited settings</heading><paragraph>Amoxicillin is recommended by the World Health Organization for the treatment of infants with signs and symptoms of pneumonia in resource-limited situations when the parents are unable or unwilling to accept hospitalization of the child. Amoxicillin in combination with gentamicin is recommended for the treatment of infants with signs of other severe infections when hospitalization is not an option.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.ncbi.nlm.nih.gov/books/NBK321136/<space/></arg><arg name="title">Guideline: Managing Possible Serious Bacterial Infection in Young Infants When Referral Is Not Feasible - NCBI Bookshelf<space/></arg><arg name="format"><space/></arg><arg name="work"><space/></arg><arg name="accessdate"></arg></template></extension></paragraph><heading level='3'>Prevention of bacterial endocarditis</heading><paragraph>It is also used to prevent<space/><link><target>bacterial endocarditis</target></link><space/>in high-risk people having dental work done, to prevent<space/><italics><link><target>Streptococcus pneumoniae</target></link></italics><space/>and other encapsulated bacterial infections in those without<space/><link><target>spleen</target><trail>s</trail></link>, such as people with<space/><link><target>sickle-cell disease</target></link>, and for both the prevention and the treatment of<space/><link><target>anthrax</target></link>.<extension extension_name='ref' name="AHFS2015"></extension><space/>The United Kingdom recommends against its use for infectious endocarditis prophylaxis.<extension extension_name='ref'><template><target>cite web</target><arg name="title">CG64 Prophylaxis against infective endocarditis: Full guidance<space/></arg><arg name="url">http://www.nice.org.uk/nicemedia/live/11938/40039/40039.pdf</arg><arg name="work">NICE</arg><arg name="accessdate">8 June 2011</arg></template></extension><space/>These recommendations do not appear to have changed the rates of infection for infectious endocarditis.<extension extension_name='ref'><template><target>cite journal</target><arg name="last">Thornhill<space/></arg><arg name="first">MH<space/></arg><arg name="last2">Dayer<space/></arg><arg name="first2">MJ<space/></arg><arg name="last3">Forde<space/></arg><arg name="first3">JM<space/></arg><arg name="last4">Corey<space/></arg><arg name="first4">GR<space/></arg><arg name="last5">Chu<space/></arg><arg name="first5">VH<space/></arg><arg name="last6">Couper<space/></arg><arg name="first6">DJ<space/></arg><arg name="last7">Lockhart<space/></arg><arg name="first7">PB</arg><arg name="title">Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study</arg><arg name="journal">BMJ (Clinical research ed.)<space/></arg><arg name="date">2011-05-03<space/></arg><arg name="volume">342<space/></arg><arg name="pages">d2392<space/></arg><arg name="pmid">21540258<space/></arg><arg name="doi">10.1136/bmj.d2392<space/></arg><arg name="pmc">3086390</arg></template></extension></paragraph><heading level='3'>Combination treatment</heading><paragraph>Amoxicillin is susceptible to degradation by<space/><link><target>beta-lactamase</target><part>-lactamase</part></link>-producing bacteria, which are resistant to a narrow spectrum of -lactam antibiotics, such as<space/><link><target>penicillin</target></link>. For this reason, it may be combined with<space/><link><target>clavulanic acid</target></link>, a -lactamase inhibitor. This drug combination is commonly called<space/><link><target>Coamoxiclav</target><part>co-amoxiclav</part></link>.<extension extension_name='ref'><template><target>cite web</target><arg name="title">Amoxicillin Susceptibility and Resistance Data</arg><arg name="url">http://www.toku-e.com/Assets/MIC/AmoxicillinClavulanate%20augmentin.pdf</arg><arg name="accessdate">20 July 2013</arg></template></extension></paragraph><heading level='3'>Spectrum of activity</heading><paragraph>It is a moderate-spectrum, bacteriolytic,<space/><link><target>-Lactam antibiotic</target></link><space/>in the<space/><link><target>aminopenicillin</target></link><space/>family used to treat susceptible<space/><link><target>Gram-positive</target></link><space/>and<space/><link><target>Gram-negative</target></link><space/>bacteria. It is usually the drug of choice within the class because it is better-absorbed, following oral administration, than other -lactam antibiotics. In general,<space/><italics><link><target>Streptococcus</target></link>,<space/><link><target>Bacillus subtilis</target></link>,<space/><link><target>Enterococcus</target></link>,<space/><link><target>Haemophilus</target></link>,<space/><link><target>Helicobacter</target></link>,</italics><space/>and<space/><italics><link><target>Moraxella</target></link></italics><space/>are susceptible to amoxicillin, whereas<space/><italics><link><target>Citrobacter</target></link>,<space/><link><target>Klebsiella</target></link></italics><space/>and<space/><italics><link><target>Pseudomonas aeruginosa</target></link></italics>are resistant to it.<extension extension_name='ref'><template><target>cite web</target><arg name="title">Amoxicillin spectrum of bacterial susceptibility and Resistance</arg><arg name="url">http://www.toku-e.com/Assets/MIC/Amoxicillin%20sodium%20salt.pdf<space/></arg><arg name="accessdate">8 April 2012</arg></template></extension><space/>Some<space/><italics><link><target>E. coli</target></link></italics><space/>and most clinical strains of<space/><italics><link><target>Staphylococcus aureus</target></link></italics><space/>have developed resistance to amoxicillin to varying degrees.</paragraph><heading level='2'>Adverse effects</heading><paragraph><link><target>Adverse drug reaction</target><part>Side effect</part><trail>s</trail></link><space/>are similar to those for other<space/><link><target>-lactam antibiotic</target><trail>s</trail></link>, including<space/><link><target>nausea</target></link>, vomiting, rashes, and antibiotic-associated<space/><link><target>colitis</target></link>. Loose bowel movements (diarrhea) may also occur. Rarer side effects include mental changes, lightheadedness, insomnia, confusion, anxiety, sensitivity to lights and sounds, and unclear thinking. Immediate medical care is required upon the first signs of these side effects.</paragraph><paragraph>The onset of an allergic reaction to amoxicillin can be very sudden and intense; emergency medical attention must be sought as quickly as possible. The initial phase of such a reaction often starts with a change in mental state, skin rash with intense itching (often beginning in fingertips and around groin area and rapidly spreading), and sensations of fever, nausea, and vomiting. Any other symptoms that seem even remotely suspicious must be taken very seriously. However, more mild allergy symptoms, such as a rash, can occur at any time during treatment, even up to a week after treatment has ceased. For some people allergic to amoxicillin, the side effects can be fatal due to<space/><link><target>anaphylaxis</target></link>.</paragraph><paragraph>Use of the amoxicillin/clavulanic acid combination for more than one week has caused mild<space/><link><target>hepatitis</target></link><space/>in some patients. Young children having ingested acute overdoses of amoxicillin manifested<space/><link><target>lethargy</target></link>, vomiting, and<space/><link><target>Renal failure</target><part>renal dysfunction</part></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="title"><space/>Amoxicillin-clavulanic acid-induced hepatitis<space/></arg><arg name="journal"><space/>Amer. J. Otolaryngol.<space/></arg><arg name="volume"><space/>28<space/></arg><arg name="pages"><space/>28–30</arg><arg name="year"><space/>2007<space/></arg><arg name="author"><space/>Cundiff j<space/></arg><arg name="first"><space/>Joe S.<space/></arg><arg name="doi"><space/>10.1016/j.amjoto.2006.06.007<space/></arg><arg name="pmid"><space/>17162128<space/></arg><arg name="last2"><space/>Joe<space/></arg><arg name="first2"><space/>S<space/></arg><arg name="issue"><space/>1</arg></template></extension><extension extension_name='ref'><template><target>cite book</target><arg name="author"><space/>R. Baselt<space/></arg><arg name="title"><space/>Disposition of Toxic Drugs and Chemicals in Man<space/></arg><arg name="edition"><space/>8th<space/></arg><arg name="publisher"><space/>Biomedical Publications<space/></arg><arg name="location"><space/>Foster City, CA<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pages"><space/>81–83</arg></template></extension></paragraph><heading level='3'>Nonallergic rash</heading><paragraph>Between 3 and 10% of children taking amoxicillin (or<space/><link><target>ampicillin</target></link>) show a late-developing (&gt;72 hours after beginning medication and having never taken penicillin-like medication previously) rash, which is sometimes referred to as the &quot;amoxicillin rash&quot;. The rash can also occur in adults.</paragraph><paragraph>The rash is described as<space/><link><target>maculopapular</target></link><space/>or morbilliform (<link><target>Measles</target><part>measles-like</part></link>; therefore, in medical literature, it is called &quot;amoxicillin-induced morbilliform rash&quot;.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://cat.inist.fr/?aModele</arg><arg name="title">Role of delayed cellular hypersensitivity and adhesion molecules in amoxicillin-induced morbilliform rashes<space/></arg><arg name="publisher">Cat.inist.fr<space/></arg><arg name="accessdate">2010-11-13</arg></template></extension>) It starts on the trunk and can spread from there. This rash is unlikely to be a true allergic reaction, and is not a contraindication for future amoxicillin usage, nor should the current regimen necessarily be stopped. However, this common amoxicillin rash and a dangerous allergic reaction cannot easily be distinguished by inexperienced persons, so a healthcare professional is often required to distinguish between the two.<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Pichichero ME<space/></arg><arg name="title">A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients<space/></arg><arg name="journal">Pediatrics<space/></arg><arg name="volume">115<space/></arg><arg name="issue">4<space/></arg><arg name="pages">1048–57<space/></arg><arg name="date">April 2005<space/></arg><arg name="pmid">15805383<space/></arg><arg name="doi">10.1542/peds.2004-1276<space/></arg><arg name="url">http://pediatrics.aappublications.org/cgi/content/full/115/4/1048</arg></template></extension><extension extension_name='ref'><template><target>cite book</target><arg name="author">Schmitt, Barton D.<space/></arg><arg name="title">Your child's health: the parents' one-stop reference guide to symptoms, emergencies, common illnesses, behavior problems, healthy development<space/></arg><arg name="edition">2nd<space/></arg><arg name="publisher">Bantam Books<space/></arg><arg name="location">New York<space/></arg><arg name="year">2005<space/></arg><arg name="pages"><space/></arg><arg name="isbn">0-553-38369-8<space/></arg><arg name="oclc"><space/></arg><arg name="doi"><space/></arg><arg name="accessdate"></arg></template></extension></paragraph><paragraph>A nonallergic amoxicillin rash may also be an indicator of<space/><link><target>infectious mononucleosis</target></link>. Some studies indicate about 80-90% of patients with acute<space/><link><target>Epstein Barr virus</target></link><space/>infection treated with amoxicillin or ampicillin develop such a rash.<extension extension_name='ref'><template><target>cite journal</target><arg name="last">Kagan<space/></arg><arg name="first">B<space/></arg><arg name="title">Ampicillin rash<space/></arg><arg name="journal">Western Journal of Medicine<space/></arg><arg name="volume">126<space/></arg><arg name="issue">4<space/></arg><arg name="pages">333–335<space/></arg><arg name="year">1977<space/></arg><arg name="pmid">855325<space/></arg><arg name="pmc">1237570</arg></template></extension></paragraph><paragraph><table style='border-collapse: collapse; border: 1px solid grey;'><tablerow><tablecell valign="top" align="left"><link><target>Image:Amoxicillin rash 3 hours after 17th dose.JPG</target><part>thumb</part><part>center</part><part></part></link><xhtml:br></xhtml:br>Nonallergic amoxicillin rash eight days after first dose: This photo was taken 24 hours after the rash began.</tablecell><tablecell valign="top" align="left"><link><target>Image:Amoxicillin rash 11 hours after 17th dose.JPG</target><part>thumb</part><part>center</part><part></part></link><xhtml:br></xhtml:br>Eight hours after the first photo, individual spots have grown and begun to merge.</tablecell><tablecell valign="top" align="left"><link><target>Image:Amoxicillin rash 26 hours after 17th dose.JPG</target><part>thumb</part><part>center</part><part></part></link><xhtml:br></xhtml:br>At 23 hours after the first photo, the color appears to be fading, and much of rash has spread to confluence.</tablecell></tablerow></table></paragraph><heading level='2'>Interaction</heading><paragraph>Amoxicillin may interact with these drugs:</paragraph><list type='bullet'><listitem>Anticoagulants (e.g.,<space/><link><target>warfarin</target></link>,<space/><link><target>dabigatran</target></link>)<extension extension_name='ref' name="bnf57">British National Formulary 57 March 2009</extension></listitem><listitem><link><target>Allopurinol</target></link><space/>(gout treatment)</listitem><listitem>Certain antibiotics</listitem><listitem>Cancer treatment (<link><target>methotrexate</target></link>)</listitem><listitem>Uricosuric drugs</listitem><listitem>Typhoid vaccine</listitem></list><heading level='2'>Mechanism of actions</heading><paragraph><template><target>Main</target><arg>Beta-lactam antibiotic</arg></template></paragraph><paragraph>This drug acts by inhibiting the synthesis of bacterial<space/><link><target>cell wall</target><trail>s</trail></link>. It inhibits<space/><link><target>cross-link</target><trail>age</trail></link><space/>between the linear peptidoglycan polymer chains that make up a major component of the<space/><link><target>cell wall</target><trail>s</trail></link><space/>of both<space/><link><target>Gram-positive bacteria</target><part>Gram-positive</part></link><space/>and<space/><link><target>Gram-negative bacteria</target></link>.</paragraph><paragraph>It has two<space/><link><target>ionizable</target></link><space/>groups in the physiological range (the amino group in alpha-position to the amide carbonyl group and the carboxyl group).</paragraph><heading level='2'>History</heading><paragraph><template><target>see also</target><arg>Timeline of antibiotics</arg></template>Amoxicillin was one of several<space/><link><target>semisynthesis</target><part>semisynthetic</part></link><space/>derivatives of 6-aminopenicillanic acid (<link><target>6-APA</target></link>) developed at<space/><link><target>Beecham Group</target><part>Beecham, England</part></link><space/>in the 1960s. It became available in 1972, and was the second<space/><link><target>aminopenicillin</target></link><space/>to reach the market (after<space/><link><target>ampicillin</target></link><space/>in 1961).<extension extension_name='ref'><template><target>cite journal</target><arg name="last1"><space/>Geddes<space/></arg><arg name="first1"><space/>AM<space/></arg><arg name="display-authors"><space/>1<space/></arg><arg name="last2"><space/>et al<space/></arg><arg name="date"><space/>Dec 2007<space/></arg><arg name="title"><space/>Introduction: historical perspective and development of amoxicillin/clavulanate<space/></arg><arg name="url"><space/></arg><arg name="journal"><space/>Int J Antimicrob Agents<space/></arg><arg name="volume"><space/>30<space/></arg><arg name="issue"><space/>Suppl 2</arg><arg name="pages"><space/>S109–12<space/></arg><arg name="pmid"><space/>17900874<space/></arg><arg name="doi">10.1016/j.ijantimicag.2007.07.015</arg></template></extension><extension extension_name='ref' name="Ravina"><template><target>cite book</target><arg name="last">Raviña<space/></arg><arg name="first">E<space/></arg><arg name="title">The Evolution of Drug Discovery<space/></arg><arg name="publisher">Wiley-VCH<space/></arg><arg name="location">Weinheim<space/></arg><arg name="year">2014<space/></arg><arg name="page">262<space/></arg><arg name="isbn">9783527326693</arg></template></extension><extension extension_name='ref'><template><target>cite book</target><arg name="last">Bruggink<space/></arg><arg name="first">A<space/></arg><arg name="title">Synthesis of β-lactam antibiotics<space/></arg><arg name="publisher">Springer<space/></arg><arg name="year">2001<space/></arg><arg name="page">17<space/></arg><arg name="isbn">0-7923-7060-0</arg></template></extension><space/><link><target>Coamoxiclav</target><part>Co-amoxiclav</part></link><space/>became available in 1981.<extension extension_name='ref' name="Ravina"></extension></paragraph><heading level='2'>Society and culture</heading><paragraph>Amoxicillin is the<space/><link><target>International Nonproprietary Name</target><part>INN</part></link><space/>and<space/><link><target>British Approved Name</target><part>BAN</part></link><space/>name while amoxycillin is the<space/><link><target>Australian Approved Name</target><part>AAN</part></link>.</paragraph><heading level='3'>Modes of delivery</heading><paragraph>Pharmaceutical manufacturers make amoxicillin in<space/><link><target>Hydrate</target><part>trihydrate</part></link><space/>form, for oral use available as capsules, chewable and dispersible<space/><link><target>Tablet (pharmacy)</target><part>tablets</part></link>, syrup and<space/><link><target>pediatrics</target><part>pediatric</part></link><space/><link><target>Suspension (chemistry)</target><part>suspension</part></link><space/>for oral use, and as the sodium salt for<space/><link><target>intravenous</target></link><space/>administration. Amoxicillin is most commonly taken orally. The liquid forms are helpful where the patient might find it difficult to take tablets or capsules.Intravenous form is not sold in USA</paragraph><paragraph>Research with mice indicated successful delivery using<space/><link><target>intraperitoneally</target></link><space/>injected amoxicillin-bearing<space/><link><target>microparticles</target></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="title"><space/>Amoxicillin-bearing microparticles: potential in the treatment of Listeria monocytogenes infection in Swiss albino mice<space/></arg><arg name="url"><space/>http://www.bioscirep.org/bsr/031/bsr0310265.htm<space/></arg><arg name="journal"><space/>Bioscience Reports<space/></arg><arg name="year"><space/>2011<space/></arg><arg name="volume"><space/>31<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="doi"><space/>10.1042/BSR20100027<space/></arg><arg name="last1"><space/>Farazuddin<space/></arg><arg name="first1"><space/>Mohammad<space/></arg><arg name="last2"><space/>Chauhan<space/></arg><arg name="first2"><space/>Arun<space/></arg><arg name="last3"><space/>Khan<space/></arg><arg name="first3"><space/>Raza M.M.<space/></arg><arg name="last4"><space/>Owais<space/></arg><arg name="first4"><space/>Mohammad<space/></arg><arg name="pages"><space/>265–72<space/></arg><arg name="pmid"><space/>20687896</arg></template></extension></paragraph><heading level='3'>Names</heading><paragraph>Amoxicillin is the<space/><link><target>International Nonproprietary Name</target><part>INN</part></link>,<space/><link><target>British Approved Name</target><part>BAN</part></link>, and<space/><link><target>United States Adopted Name</target><part>USAN</part></link>) while<space/><bold>amoxycillin</bold><space/>is the<space/><link><target>Australian Approved Name</target><part>AAN</part></link>.</paragraph><paragraph>Amoxicillin is one of the semisynthetic penicillins discovered by<space/><link><target>Beecham (pharmaceutical company)</target><part>Beecham</part></link><space/>scientists. The patent for amoxicillin has expired, thus amoxicillin and co-amoxiclav preparations are marketed under many trade names and/or have several synonyms across the world, such as:<template><target>div col</target><arg name="colwidth">8em</arg></template></paragraph><list type='bullet'><listitem>Actimoxi<extension extension_name='ref'><link type='external' href='http://www.catalog.md/drugs/actimoxi.html'>Catalog.md: Actimoxi</link><space/>Linked 2013-12-09</extension></listitem><listitem>Alphamox</listitem><listitem>Amimox</listitem><listitem>AMOXIZIF</listitem><listitem>Amocla</listitem><listitem>AMK</listitem><listitem>Amoksiklav</listitem><listitem>Amorion</listitem><listitem>Amoxibactin (animal use)</listitem><listitem>Amoxibos</listitem><listitem>Amoxiclav</listitem><listitem>Amoxidal</listitem><listitem>Amoxil</listitem><listitem>Amoxin<extension extension_name='ref'><link type='external' href='http://www.ndrugs.com?s=amoxin'>Amoxin</link><space/>Linked 2014-07-23</extension></listitem><listitem>Amoxibiotic<extension extension_name='ref'><link type='external' href='http://www.catalog.md/drugs/amoxibiotic.html'>Catalog.md: Amoxibiotic</link><space/>Linked 2013-12-09</extension></listitem><listitem>Amoxicilina</listitem><listitem>Amoxidal</listitem><listitem>Amoxoral (animal use)</listitem><listitem>Apo-Amoxy</listitem><listitem>Arsogil<extension extension_name='ref'><link type='external' href='http://www.aversi.ge/annotations.php?id=73&amp;amp;lang=geo&amp;amp;drug_id=44400'>Aversi (Georgia): Arsogil</link><space/>Linked 2013-12-09</extension></listitem><listitem>Augmentin<space/></listitem><listitem>Bactox</listitem><listitem>Bioxidona<extension extension_name='ref'><link type='external' href='http://www.catalog.md/drugs/bioxidona.html'>Catalog.md: Bioxidona</link><space/>Linked 2013-12-09</extension></listitem><listitem>Cilamox</listitem><listitem>Clamoxyl</listitem><listitem>Clavamox</listitem><listitem>Clonamox</listitem><listitem>Curam</listitem><listitem>Dedoxil</listitem><listitem>Dispermox</listitem><listitem>Duomox</listitem><listitem>Defender<extension extension_name='ref'><link type='external' href='http://www.drugsupdate.com/brand/generic/Amoxicillin%20+%20Clavulanic%20Acid/45673'>DrugsUpdate India: Defender from Sac Pharma</link><space/>Linked 2013-12-09</extension></listitem><listitem>E-Mox<extension extension_name='ref'><link type='external' href='http://www.eipico.com.eg/PRODUCT.ASP?id1=4&amp;amp;id2=1%20&amp;amp;id4=2'>Eipico (Egypt): E-Mox</link><space/>Linked 2013-12-09</extension></listitem><listitem>Enhancin</listitem><listitem>Ezymox<extension extension_name='ref'><link type='external' href='http://www.drugsupdate.com/brand/generic/Amoxicillin/45866'>DrugsUpdate India: Ezymox from Sac Pharma</link><space/>Linked 2013-12-09</extension></listitem><listitem>Gimalxina</listitem><listitem>Geramox</listitem><listitem>Hiconcil</listitem><listitem>Himox</listitem><listitem>Isimoxin<extension extension_name='ref'><link type='external' href='http://www.catalog.md/drugs/isimoxin.html'>Catalog.md: Isimoxin</link><space/>Linked 2013-12-09</extension></listitem><listitem>Klavax</listitem><listitem>Klavocin</listitem><listitem>Klavox</listitem><listitem>Lamoxy</listitem><listitem>Largopen</listitem><listitem>MOX</listitem><listitem>Moxatag</listitem><listitem>Moxiclav Duo<space/><extension extension_name='ref'><link type='external' href='http://www.aspenpharma.com.au/products/details/index/id/998/product/Moxiclav%20Duo%20500/125'></link></extension></listitem><listitem>Moxilen</listitem><listitem>Moxypen</listitem><listitem>Moxyvit</listitem><listitem>Nobactam</listitem><listitem>Novamoxin</listitem><listitem>Optamox</listitem><listitem>Ospamox</listitem><listitem>Pamoxicillin</listitem><listitem>Panklav<space/></listitem><listitem>Pinamox</listitem><listitem>Penamox</listitem><listitem>Polymox</listitem><listitem>Senox<space/><extension extension_name='ref'><link type='external' href='http://bioportal.bioontology.org/ontologies/RXNORM?p=classes&amp;amp;conceptid=http%3A%2F%2Fpurl.bioontology.org%2Fontology%2FRXNORM%2F205721'>BioPortal: Senox</link><space/>Linked 2013-12-09</extension></listitem><listitem>Sinacilin</listitem><listitem>Skymox<extension extension_name='ref'><link type='external' href='http://www.pakmedinet.com/trade.php?id=1449'>PalMediNet: Skymox</link><space/>Linked 2013-12-09</extension></listitem><listitem>Spektramox<space/></listitem><listitem>Starmox<extension extension_name='ref'><link type='external' href='http://www.sarthakasia.com/sarthakbiotech/tablets.htm'>Sarthak Biotech India: Starmox</link><space/>Linked 2013-12-09</extension></listitem><listitem>Trimox</listitem><listitem>Tolodina<extension extension_name='ref'><link type='external' href='http://www.catalog.md/drugs/tolodina.html'>Catalog.md: Tolodina</link><space/>Linked 2013-12-09</extension></listitem><listitem>Tormoxin</listitem><listitem>Tyclav<extension extension_name='ref'><link type='external' href='http://beximco-pharma.com/anti-infectives/5341-tyclav.html'>Beximco Pharma, Bangladesh: Tyclav</link><space/>Linked 2013-12-09</extension></listitem><listitem>Unimox</listitem><listitem>Vidamox</listitem><listitem>Wedemox</listitem><listitem>Wymox</listitem><listitem>Yucla</listitem><listitem>remox</listitem><listitem>Zerrsox</listitem><listitem>Zimox</listitem><listitem>Zoxicillin<extension extension_name='ref'><link type='external' href='http://www.pakmedinet.com/trade.php?id=1462'>PakMediNet (Pakistan): Zoxicillin</link><space/>Linked 2013-12-09</extension></listitem></list><paragraph><template><target>div col end</target></template>Names without individual reference are referenced on the drugs.com website.<extension extension_name='ref'><link type='external' href='http://www.drugs.com/international/amoxicillin.html'>Drugs.com: Amoxicillin</link><space/>Linked 2013-12-09</extension></paragraph><heading level='2'>References</heading><paragraph><template><target>Reflist</target><arg>30em</arg></template></paragraph><heading level='2'>Further reading</heading><list type='bullet'><listitem><template><target>cite book</target><arg name="author">Neal, M. J.<space/></arg><arg name="title">Medical pharmacology at a glance<space/></arg><arg name="publisher">Blackwell Science<space/></arg><arg name="location">Oxford<space/></arg><arg name="edition">4th<space/></arg><arg name="year">2002<space/></arg><arg name="pages"><space/></arg><arg name="isbn">0-632-05244-9<space/></arg><arg name="oclc"><space/></arg><arg name="doi"><space/></arg><arg name="accessdate"></arg></template></listitem></list><list type='bullet'><listitem><link><target>British National Formulary</target></link><space/><italics>45</italics><space/>March 2003</listitem></list><heading level='2'>External links</heading><list type='bullet'><listitem><link type='external' href='http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Amoxicillin+anhydrous'>U.S. National Library of Medicine: Drug Information Portal - Amoxicillin</link></listitem></list><paragraph><template><target>PenicillinAntiBiotics</target></template><template><target>GlaxoSmithKline</target></template></paragraph><paragraph><link><target>Category:Beta-lactam antibiotics</target></link><link><target>Category:Enantiopure drugs</target></link><link><target>Category:World Health Organization essential medicines</target></link><link><target>Category:Phenols</target></link><link><target>Category:Carboxylic acids</target></link><link><target>Category:RTT</target></link></paragraph></article>